TG Therapeutics Plans Cut-Price Challenger To Ocrevus In MS

Filing Expected In Q3

Brain with MS
An MRI of the brain of an MS patient, yellow-gold-orange showing areas of demyelination. • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Anticancer

More from Therapy Areas